Emerging Company Profile
Xilis: developing miniature cancer organoids
Emerging Company Profile: Xilis raises $70M led by Mubadala to advance tech for cancer drug development, treatment selection
With its $70 million series A round, Xilis will advance its miniature organoid technology to accelerate cancer drug development and guide treatment selection.
Jul 9, 2021 | 12:50 AM GMT